|
Market Closed -
NSE India S.E.
07:05:10 2026-08-21 EDT
|
5-day change | 1st Jan Change | ||
| 1,902.40 INR | -0.08% |
|
-1.43% | +10.62% |
| 08-05 | CRISIL Keeps AAA Rating on Sun Pharmaceutical's Bank Facilities | MT |
| 07-31 | Sun Pharmaceutical Industries Limited, Q1 2027 Earnings Call, Jul 31, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 47.71B | |||||
| 40.3B | |||||
| 12.09B | |||||
| 11.68B | |||||
| 9.19B | |||||
| 7.57B |
Select your edition
All financial news and data tailored to specific country editions
